Table 2

Findings related to study characteristics

 Sources*
Study designRCT=24(1, 3, 5, 6, 7, 8, 10, 11, 14, 17, 18, 19, 20, 22, 23, 27, 28, 329, 31, 33, 34, 35, 36)
Longitudinal=8(2, 12, 13, 16, 24, 25, 26, 30),
Mix method=3(8, 21, 32)
Case studies=2(4, 15)
SampleMean=1157.42
Median=385.00
SD=1749.96
All
Follow-up periodMean=10.52
Median=6.00
SD=9.80
(All except 33)
Adherence rate/uptake rate1=yes=31 (78.9%)
0=no=6 (21.1%)
(1–8, 10, 12–14, 16–19, 20–24, 26–31, 33, 34, 36, 37)
Outcomes related to physical activity1=yes=17 (42.1%)
0=no=20 (39.47%)
(3, 5, 6, 7, 10, 11, 14, 15, 17, 21, 22, 27, 28, 34, 35, 36, 37)
Outcomes related to mental health and quality of life1=yes=11 (28.9)
0=no=26 (71.1)
(5, 7, 9, 10, 11, 17, 18, 19, 28, 31, 32)
Cost-effectiveness1=yes=2
0=no=36
(5,29)
Country of originUK=13 (2, 3, 4, 5, 12, 13, 14, 15, 16, 22, 28, 37)
Sweden=7 (17, 18, 19, 24, 25, 26, 31)
NL=2 (7, 31)
Denmark=3 (30, 34, 35)
Finland=1 (20)
Spain=2 (9, 10, 11)
Germany=1 (6)
Canada=2 (8, 21)
USA=3 (1, 29, 33)
New Zealand=1(23)
Australia=1(27)
  • *Numbers in brackets present the number of the study listed in online supplementary appendix 1.

  • RCT, randomised controlled trial.